Search

Showing "11155" results for ""

Drug safety bodies issue warning on heart rhythm risks with saquinavir (Invirase)

Fixed dose ARV for children: half-dose to limit nevirapine rash is safe in first 2 weeks

New model shows future impact of circumcision on Africa's HIV epidemic probably underestimated

Darunavir working well for highly treatment-experienced patients in Switzerland

Sensitive test finds high rate of transmitted drug-resistant HIV in UK

FDA will give fast-track to tenofovir gel approval

Accelerated hepatitis B vaccine schedule boosts completion rates in IDUs

Nurse attitudes, clinic experience, key to improving care and retention in ARV programmes

High hepatitis C mortality and low clearance rates in HIV/HCV-co-infected patients in France

People who stigmatise HIV are less likely to take an HIV test

News in brief

HIV and the kidneys

Do HIV drugs really mean you aren’t infectious?

Craig's incredible bike ride

What you think about HTU now, and for the future

Staying safe inside: HIV and hepatitis C health care in prison

New tool developed to predict success of hepatitis C therapy in HIV/HCV-co-infected patients

Reconstructive surgery for facial fat loss is feasible and safe for patients with HIV

Receive the latest HIV research and conference news

Showing "11155" results for ""

Drug safety bodies issue warning on heart rhythm risks with saquinavir (Invirase)

Fixed dose ARV for children: half-dose to limit nevirapine rash is safe in first 2 weeks

New model shows future impact of circumcision on Africa's HIV epidemic probably underestimated

Darunavir working well for highly treatment-experienced patients in Switzerland

Sensitive test finds high rate of transmitted drug-resistant HIV in UK

FDA will give fast-track to tenofovir gel approval

Accelerated hepatitis B vaccine schedule boosts completion rates in IDUs

Nurse attitudes, clinic experience, key to improving care and retention in ARV programmes

High hepatitis C mortality and low clearance rates in HIV/HCV-co-infected patients in France

People who stigmatise HIV are less likely to take an HIV test

News in brief

HIV and the kidneys

Do HIV drugs really mean you aren’t infectious?

Craig's incredible bike ride

What you think about HTU now, and for the future

Staying safe inside: HIV and hepatitis C health care in prison

New tool developed to predict success of hepatitis C therapy in HIV/HCV-co-infected patients

Reconstructive surgery for facial fat loss is feasible and safe for patients with HIV

Receive the latest HIV research and conference news